Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies

BACKGROUND: Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report difficulty with sleep. METHODS: We examined the effect of omalizumab on sleep-related outcomes during 3–6 months omalizumab or placebo treatment and a 16-week follow-up period within three Phase III double-blind rand...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Allergy
Main Authors: Gimenéz-Arnau, Ana M., Spector, Sheldon, Antonova, Evgeniya, Trzaskoma, Benjamin, Rosén, Karin, Omachi, Theodore A., Stull, Donald, Balp, Maria-Magdalena, Murphy, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4989527/
https://ncbi.nlm.nih.gov/pubmed/27540466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-016-0120-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados